Back to results
CompletedEARLY_Phase 1

HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer

NCT03387553

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

H. Lee Moffitt Cancer Center and Research Institute

Tampa, Florida, United States

View on ClinicalTrials.gov
HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer — TrialFind